Sugi Predict

Sugi Predict / Compounds / SCHEMBL17646349

SCHEMBL17646349

SCHEMBL17646349

O=C(NCCCC[C@H](NC(=O)C1CCCC1)C(=O)c1ccccn1)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TGM2 P21980 2/20 0.51
▸ ANPEP P15144 1/20 0.51
▸ ITGB3 P05106 1/20 0.50
▸ ITGA2B P08514 1/20 0.50
▸ FOLH1 Q04609 3/20 0.49
▸ HTRA1 Q92743 1/20 0.47
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ MMP2 P08253 1/20 0.45
▸ MMP9 P14780 1/20 0.45
▸ KLK7 P49862 1/20 0.44
▸ KLK5 Q9Y337 1/20 0.44
▸ DPP4 P27487 1/20 0.44
▸ DPP8 Q6V1X1 1/20 0.44
▸ DPP9 Q86TI2 1/20 0.44
▸ DPP7 Q9UHL4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19665781 1.00 TGM2 (0.51) TGM2ANPEPITGB3ITGA2BFOLH1
SCHEMBL17646277 0.86 F2 (0.49) ANPEPITGB3ITGA2BFOLH1MMP2
SCHEMBL10770977 0.85 FOLH1 (0.64) ITGB3ITGA2BFOLH1MMP2MMP9
SCHEMBL7323375 0.84 FOLH1 (0.66) ITGB3ITGA2BFOLH1MMP2MMP9
SCHEMBL28344054 0.82 MAPT (0.61) TGM2ANPEPITGB3ITGA2BFOLH1
SCHEMBL17646390 0.82 MAPT (0.61) TGM2ANPEPITGB3ITGA2BFOLH1
SCHEMBL10772400 0.82 FOLH1 (0.68) ITGB3FOLH1MMP2MMP9
SCHEMBL28341581 0.81 HDAC3 (0.51) ITGB3ITGA2BFOLH1HDAC1HDAC2
SCHEMBL17646234 0.81 HDAC3 (0.51) ITGB3ITGA2BFOLH1HDAC1HDAC2
SCHEMBL22150083 0.80 HDAC3 (0.50) ITGB3ITGA2BHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332464-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-17 — — US disclosed
US-20210017167-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-01-21 — — US disclosed
EP-3204352-B1 INHIBITORS OF LYSINE GINGIPAIN CORTEXYME INC (US) 2020-07-01 — — EP disclosed
CN-111349053-A Inhibitors of lysine porphyromonas gingivalis protease 库特克希米公司 2020-06-30 — — CN disclosed
US-10676470-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-06-09 — — US disclosed
CN-107108468-B Inhibitors of lysine porphyromonas gingivalis protease 库特克希米公司 2020-01-03 — — CN disclosed
US-20190322659-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-10-24 — — US disclosed
US-10301301-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2019-05-28 — — US disclosed
US-20180346460-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2018-12-06 — — US disclosed
US-9988375-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2018-06-05 — — US disclosed
US-20170349537-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2017-12-07 — — US disclosed
US-9758473-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2017-09-12 — — US disclosed
US-9758473-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2017-09-12 — — US disclosed
US-9758473-B2 Inhibitors of lysine gingipain Cortexyme, Inc. (US) 2017-09-12 — — US disclosed
EP-3204352-A2 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2017-08-16 — — EP disclosed
WO-2016057413-A2 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-14 — — WO disclosed
WO-2016057413-A2 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-14 — — WO disclosed
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-07 — — US disclosed
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-07 — — US disclosed
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2016-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180346460-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-20190322659-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-20210017167-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-10676470-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-20170349537-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-20160096830-A1 INHIBITORS OF LYSINE GINGIPAIN ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-11332464-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885
US-10301301-B2 Inhibitors of lysine gingipain ENPEP, PHYKPL, PREP TGM2 326/4885ANPEP 21/4885ITGB3 3890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.